Gallimore AM - Search Results

1

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.

Pembroke T, Rees I, Gallagher K, Jones E, Mizen P, Navruzov T, Freedman A, Fielding C, Humphreys IR, Wang EC, Gallimore AM, Godkin A. Pembroke T, et al. Among authors: gallimore am. Eur J Immunol. 2012 Sep;42(9):2383-94. doi: 10.1002/eji.201142072. Epub 2012 Aug 6. Eur J Immunol. 2012. PMID: 22653709 Free PMC article.

2

Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered.

Bachmann MF, Gallimore A, Jones E, Ecabert B, Acha-Orbea H, Kopf M. Bachmann MF, et al. Eur J Immunol. 2001 Feb;31(2):450-8. doi: 10.1002/1521-4141(200102)31:2<450::aid-immu450>3.0.co;2-x. Eur J Immunol. 2001. PMID: 11180109 Free article.

3

Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment.

Leung RK, Thomson K, Gallimore A, Jones E, Van den Broek M, Sierro S, Alsheikhly AR, McMichael A, Rahemtulla A. Leung RK, et al. Nat Immunol. 2001 Dec;2(12):1167-73. doi: 10.1038/ni733. Nat Immunol. 2001. PMID: 11694883

4

CD25+ regulatory T cells and tumor immunity.

Jones E, Dahm-Vicker M, Golgher D, Gallimore A. Jones E, et al. Immunol Lett. 2003 Jan 22;85(2):141-3. doi: 10.1016/s0165-2478(02)00240-7. Immunol Lett. 2003. PMID: 12527220 Review.

5

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.

Golgher D, Jones E, Powrie F, Elliott T, Gallimore A. Golgher D, et al. Eur J Immunol. 2002 Nov;32(11):3267-75. doi: 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1. Eur J Immunol. 2002. PMID: 12555672 Free article.

6

The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells.

Jones E, Price DA, Dahm-Vicker M, Cerundolo V, Klenerman P, Gallimore A. Jones E, et al. Immunology. 2003 May;109(1):68-75. doi: 10.1046/j.1365-2567.2003.01636.x. Immunology. 2003. PMID: 12709019 Free PMC article.

7

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.

Probst HC, Tschannen K, Gallimore A, Martinic M, Basler M, Dumrese T, Jones E, van den Broek MF. Probst HC, et al. J Immunol. 2003 Nov 15;171(10):5415-22. doi: 10.4049/jimmunol.171.10.5415. J Immunol. 2003. PMID: 14607945

8

The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice.

Jones E, Golgher D, Simon AK, Dahm-Vicker M, Screaton G, Elliott T, Gallimore A. Jones E, et al. Novartis Found Symp. 2004;256:149-52; discussion 152-7, 259-69. Novartis Found Symp. 2004. PMID: 15027488 Review.

9

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen.

Bushell A, Jones E, Gallimore A, Wood K. Bushell A, et al. J Immunol. 2005 Mar 15;174(6):3290-7. doi: 10.4049/jimmunol.174.6.3290. J Immunol. 2005. PMID: 15749860

10

Regulating the immune response to tumours.

Betts GJ, Clarke SL, Richards HE, Godkin AJ, Gallimore AM. Betts GJ, et al. Among authors: gallimore am. Adv Drug Deliv Rev. 2006 Oct 1;58(8):948-61. doi: 10.1016/j.addr.2006.05.006. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070961 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters